Multicellular spheroids. A review on cellular aggregates in cancer research
- PMID: 3549738
- PMCID: PMC12248366
- DOI: 10.1007/BF00391431
Multicellular spheroids. A review on cellular aggregates in cancer research
Abstract
Cellular aggregates have been used in developmental biology and in experimental cancer research for several decades. Spherical aggregates of malignant cells, i.e. multicellular tumor spheroids, may serve as in vitro models of tumor microregions and of an early, avascular stage of tumor growth. The similarities between the original tumor and the respective spheroids include volume growth kinetics, cellular heterogeneity, e.g. the induction of proliferation gradients and quiescence, as well as differentiation characteristics, such as the development of specific histological structures or the expression of antigens. Research using cell aggregates has been focussed on mechanisms involved in the control of proliferation, invasion and metastasis. Immunological studies with spheroids have resulted in the characterization of defense cells which are responsible for specific host-versus-tumor reactions. The vast majority of investigations on spheroids concerns the simulation of therapy with regard to various treatment modalities, combination treatments and systematic analyses of using various endpoints in predictive assays. Only a few pathophysiological studies on the interrelationship among tumor-specific micromilieu, cellular metabolism, proliferative status, and cellular viability have been undertaken with the spheroid model up to now. Since these studies are indicative of a large influence of the cellular microenvironment on basic biological properties of cancer cells, investigations of these epigenetic mechanisms should be intensified in future research on cell aggregates. Similarly, the molecular basis of the biological peculiarities found in malignant cells grown as three-dimensional aggregates has to be investigated more intensively.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
Cited by
-
A preclinical model of cutaneous melanoma based on reconstructed human epidermis.Sci Rep. 2022 Sep 29;12(1):16269. doi: 10.1038/s41598-022-19307-0. Sci Rep. 2022. PMID: 36175453 Free PMC article.
-
Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters.Eur Biophys J. 1991;19(4):169-81. doi: 10.1007/BF00196343. Eur Biophys J. 1991. PMID: 2029873
-
A multicellular tumor spheroid model of cellular immunity against head and neck cancer.Cancer Immunol Immunother. 1990;32(3):195-200. doi: 10.1007/BF01771457. Cancer Immunol Immunother. 1990. PMID: 2289213 Free PMC article.
-
Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.Cancer Cell Int. 2006 Mar 23;6:6. doi: 10.1186/1475-2867-6-6. Cancer Cell Int. 2006. PMID: 16556298 Free PMC article.
-
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.Nat Rev Cancer. 2010 Apr;10(4):241-53. doi: 10.1038/nrc2820. Epub 2010 Mar 19. Nat Rev Cancer. 2010. PMID: 20300105 Review.
References
-
- Acker H (1984) Microenvironmental conditions in multicellular spheroids grown under liquid-overlay tissue culture conditions. In: Acker H, Carlsson J, Durand R, Sutherland RM (eds) Spheroids in cancer research: methods and perspectives. Springer, New York, pp 116–133 - PubMed
-
- Acker H, Carlsson J (1981) Measurements of potassium activities and membrane potentials in tumor cells. In: Lubbers DW (ed) Progress in enzyme and ion-selective electrodes. Springer, Berlin, pp 226–230
-
- Acker H, Carlsson J, Stalnacke CG (1983a) Electro-physiological measurements in cultured cellular spheroids. Acta Pathol Microbiol Immunol Scand 91:151–160 - PubMed
-
- Acker H, Holterman G, Carlsson J, Nederman T (1983b) Methodological aspects of microelectrode measurements in cellular spheroids. Adv Exp Med Biol 159:445–462 - PubMed
-
- Angello JC, Hosick HK (1982) Glycosaminoglycan synthesis by mammary tumor spheroids. Biochim Biophys Res Commun 107:1130–1137 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources